Envela (NYSEAMERICAN:ELA – Get Free Report) is scheduled to announce its earnings results on Tuesday, October 31st. Envela (NYSEAMERICAN:ELA – Get Free Report) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.02). The firm had revenue […]
Sevelamer Carbonate for Oral Suspension is a medication used to manage elevated levels of phosphate in the blood of patients with chronic kidney disease.
Envela Co. (NYSEAMERICAN:ELA – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 154,500 shares, a growth of 41.1% from the June 15th total of 109,500 shares. Based on an average daily trading volume, of 44,100 shares, […]
Envela Co. (NYSEAMERICAN:ELA – Get Rating)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $7.21. Envela shares last traded at $7.00, with a volume of 67,675 shares traded. Envela Stock Up 2.4 % The company has […]
Envela Co. (NYSEAMERICAN:ELA – Get Rating) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $7.70. Envela shares last traded at $7.59, with a volume of 34,786 shares trading hands. Envela Price Performance The company has a quick […]